(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Verb Technology Company, Verb Technology Company, and Hostess Brands.
Rank | Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|---|
1 | Verb Technology Company (VERBW) | 0.04 | 1438.46% | 2024-03-15 13:23:06 |
2 | Verb Technology Company (VERB) | 0.48 | 239.43% | 2024-03-15 13:17:06 |
3 | Hostess Brands (TWNKW) | 3.20 | 41.59% | 2024-03-15 11:14:05 |
4 | Veritone (VERI) | 3.68 | 34.75% | 2024-03-15 13:41:07 |
5 | Canopy Growth (CGC) | 3.08 | 11.19% | 2024-03-15 15:22:50 |
6 | Aurora Cannabis (ACB) | 3.18 | 10.03% | 2024-03-15 15:00:53 |
7 | FuelCell Energy (FCEL) | 1.10 | 10% | 2024-03-15 15:12:03 |
8 | Seanergy Maritime Holdings Corp (SHIPW) | 0.03 | 10% | 2024-03-14 21:23:05 |
9 | ThermoGenesis Holdings (THMO) | 0.77 | 8.76% | 2024-03-15 09:06:06 |
10 | CoStar Group (CSGP) | 95.18 | 8.32% | 2024-03-15 15:11:31 |
The three biggest losers today are Groupon, TRACON Pharmaceuticals, and Adobe.
Rank | Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|---|
1 | Groupon (GRPN) | 12.59 | -30.71% | 2024-03-15 15:12:37 |
2 | TRACON Pharmaceuticals (TCON) | 0.44 | -30.65% | 2024-03-15 07:13:06 |
3 | Adobe (ADBE) | 492.46 | -13.67% | 2024-03-15 15:10:18 |
4 | Zillow Group (Z) | 47.71 | -13.49% | 2024-03-15 15:15:24 |
5 | Zillow Group (ZG) | 46.22 | -13.02% | 2024-03-15 15:17:38 |
6 | Sutro Biopharma (STRO) | 4.01 | -12.06% | 2024-03-15 04:17:05 |
7 | Scholar Rock Holding Corporation (SRRK) | 14.78 | -9.77% | 2024-03-15 03:09:06 |
8 | ToughBuilt Industries (TBLT) | 3.25 | -9.22% | 2024-03-15 07:10:05 |
9 | DouYu (DOYU) | 0.68 | -8.94% | 2024-03-15 15:16:05 |
10 | China SXT Pharmaceuticals (SXTC) | 1.76 | -8.33% | 2024-03-15 05:10:05 |
Winners today
1. Verb Technology Company (VERBW) – 1438.46%
Verb Technology Company, Inc. develops Software-as-a-Service applications platform. It offers verbLIVE, an interactive livestream eCommerce and shoppable video and webinar application; verbCRM, a white-labelled interactive video-based customer relationship management application; verbTEAMS, a self on-boarding version of verbCRM with built-in verbLIVE for small businesses and solo entrepreneurs; verbLEARN, an interactive video and gamified learning management system application; and verbMAIL, an interactive video mail solution integrated into Microsoft Outlook. The company provides non-digital services to enterprise clients, such as printing and fulfillment services. In addition, it offers subscription-based application services. The company serves large enterprises in the life sciences sector, professional sports franchises, and other business sectors. Verb Technology Company, Inc. was founded in 2012 and is based in Lehi, Utah.
NASDAQ ended the session with Verb Technology Company rising 1438.46% to $0.04 on Friday while NASDAQ fell 0.96% to $15,973.17.
Earnings Per Share
As for profitability, Verb Technology Company has a trailing twelve months EPS of $-1.229.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.69%.
More news about Verb Technology Company.
2. Verb Technology Company (VERB) – 239.43%
Verb Technology Company, Inc. develops Software-as-a-Service applications platform. It offers verb Customer Relationship Management (CRM) application; verbLEARN, a Learning Management System application that incorporates clickable in-video technology featured in its verbCRM application; and verbLIVE, a Live Broadcast Video Webinar application. The company also provides non-digital services to enterprise clients, such as printing and fulfillment services; subscription-based application services; design and printing services to create corporate starter kits for their marketing needs; print on demand and fulfilment services of various custom products for marketing purposes; and shipping services. In addition, it provides its products for large professional associations, educational institutions, auto sales, auto leasing, insurance, real estate, home security, not-for-profits, as well as clients in the health care industry, burgeoning CBD industry, and other business sectors. The company has operations in the United States and Japan. The company was formerly known as nFüsz, Inc. and changed its name to Verb Technology Company, Inc. in February 2019. Verb Technology Company, Inc. was founded in 2014 and is headquartered in Newport Beach, California.
NASDAQ ended the session with Verb Technology Company jumping 239.43% to $0.48 on Friday, after five consecutive sessions in a row of losses. NASDAQ slid 0.96% to $15,973.17, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Verb Technology Company has a trailing twelve months EPS of $-12.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.69%.
More news about Verb Technology Company.
3. Hostess Brands (TWNKW) – 41.59%
Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes fresh sweet baked goods in the United States. It primarily offer a range of snack cakes, donuts, sweet rolls, breakfast pastries, snack pies, and related products. The company operates in two segments, Sweet Baked Goods and In-Store Bakery. The Sweet Baked Goods segment offers fresh and frozen sweet baked goods and bread products under the Hostess, Dolly Madison, Cloverhill, and Big Texas brands, as well as store branded products. The In-Store Bakery segment primarily provides Superior on Main branded eclairs, madeleines, brownies, and iced cookies in the bakery section of grocery and club stores. The company was formerly known as Gores Holdings, Inc. and changed its name to Hostess Brands, Inc. in November 2016. Hostess Brands, Inc. was founded in 1919 and is based in Lenexa, Kansas.
NASDAQ ended the session with Hostess Brands jumping 41.59% to $3.20 on Friday, after five successive sessions in a row of losses. NASDAQ fell 0.96% to $15,973.17, after two sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
PE Ratio
Hostess Brands has a trailing twelve months price to earnings ratio of 5.15. Meaning, the purchaser of the share is investing $5.15 for every dollar of annual earnings.
Moving Average
Hostess Brands’s value is below its 50-day moving average of $3.36 and way above its 200-day moving average of $2.53.
Yearly Top and Bottom Value
Hostess Brands’s stock is valued at $3.20 at 17:32 EST, way below its 52-week high of $4.02 and way higher than its 52-week low of $1.12.
More news about Hostess Brands.
4. Veritone (VERI) – 34.75%
Veritone, Inc. provides artificial intelligence (AI) and computing solutions in the United States and the United Kingdom. It develops and operates aiWARE platform, an AI operating system that integrates and orchestrates a range of cognitive engines to reveal multivariate insights from structured and unstructured data, as well as to conduct cognitive workflows based on these insights. The company also provides media advertising agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics directly to advertisers through outbound sales networking, and client and partner referrals, as well as indirectly through advertising agencies or marketing consultants. It serves media and entertainment, legal and compliance, and government markets The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.
NASDAQ ended the session with Veritone rising 34.75% to $3.68 on Friday, after two consecutive sessions in a row of gains. NASDAQ fell 0.96% to $15,973.17, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Veritone has a trailing twelve months EPS of $-1.79.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.37%.
Sales Growth
Veritone’s sales growth is 4.3% for the current quarter and 5.1% for the next.
More news about Veritone.
5. Canopy Growth (CGC) – 11.19%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth rising 11.19% to $3.08 on Friday, after two consecutive sessions in a row of losses. NASDAQ fell 0.96% to $15,973.17, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.78.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.
Yearly Top and Bottom Value
Canopy Growth’s stock is valued at $3.08 at 17:32 EST, way under its 52-week high of $21.40 and above its 52-week low of $2.81.
Sales Growth
Canopy Growth’s sales growth is negative 17.2% for the ongoing quarter and negative 17.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Canopy Growth’s EBITDA is 1.8.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 96.5% and 44.2%, respectively.
More news about Canopy Growth.
6. Aurora Cannabis (ACB) – 10.03%
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
NYSE ended the session with Aurora Cannabis jumping 10.03% to $3.18 on Friday, after two successive sessions in a row of losses. NYSE slid 0.21% to $17,848.08, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-58.69.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.4%, now sitting on 225.18M for the twelve trailing months.
Yearly Top and Bottom Value
Aurora Cannabis’s stock is valued at $3.18 at 17:32 EST, way above its 52-week high of $1.21.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Aurora Cannabis’s EBITDA is 18.09.
Volume
Today’s last reported volume for Aurora Cannabis is 1658280 which is 99.36% above its average volume of 831788.
More news about Aurora Cannabis.
7. FuelCell Energy (FCEL) – 10%
FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell and electrolysis platforms that decarbonize power and produce hydrogen. The company provides various configurations and applications of its platform, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solid oxide-based electrolysis; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. It also offers technology to produce electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, commercial and hospitality, microgrids, manufacturing, industrial hydrogen, port, oil and gas, wind and solar projects, food and beverage, hydrogen for mobility and material handling, and hydrogen fuel for heat, as well as engineering, procurement, and construction firms. The company primarily operates in the United States, South Korea, and Europe. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.
NASDAQ ended the session with FuelCell Energy rising 10% to $1.10 on Friday, after four sequential sessions in a row of losses. NASDAQ fell 0.96% to $15,973.17, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.26.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.79%.
More news about FuelCell Energy.
8. Seanergy Maritime Holdings Corp (SHIPW) – 10%
NASDAQ ended the session with Seanergy Maritime Holdings Corp jumping 10% to $0.03 on Friday, after five successive sessions in a row of losses. NASDAQ slid 0.96% to $15,973.17, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
PE Ratio
Seanergy Maritime Holdings Corp has a trailing twelve months price to earnings ratio of 0.21. Meaning, the purchaser of the share is investing $0.21 for every dollar of annual earnings.
More news about Seanergy Maritime Holdings Corp.
9. ThermoGenesis Holdings (THMO) – 8.76%
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
NASDAQ ended the session with ThermoGenesis Holdings rising 8.76% to $0.77 on Friday while NASDAQ slid 0.96% to $15,973.17.
Earnings Per Share
As for profitability, ThermoGenesis Holdings has a trailing twelve months EPS of $-7.22.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -395.62%.
More news about ThermoGenesis Holdings.
10. CoStar Group (CSGP) – 8.32%
CoStar Group, Inc. provides information, analytics, and online marketplace services to the commercial real estate, hospitality, residential, and related professionals industries in the United States, Canada, Europe, the Asia Pacific, and Latin America. The company offers CoStar Property that provides inventory of office, industrial, retail, multifamily, hospitality, and student housing properties and land; CoStar Sales, a robust database of comparable commercial real estate sales transactions; CoStar Market Analytics to view and report on aggregated market and submarket trends; and CoStar Tenant, an online business-to-business prospecting and analytical tool that provides tenant information. It also provides Leasing, a tool to capture, manage, and maintain lease data; CoStar Lease Analysis; Public Record, a searchable database of commercially zoned parcels; CoStar Real Estate Manager, a real estate lease administration, portfolio management, and lease accounting compliance software solution; and CoStar Risk Analytics and CoStar Investment. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. The company was founded in 1987 and is headquartered in Washington, the District of Columbia.
NASDAQ ended the session with CoStar Group rising 8.32% to $95.18 on Friday while NASDAQ dropped 0.96% to $15,973.17.
Earnings Per Share
As for profitability, CoStar Group has a trailing twelve months EPS of $0.92.
PE Ratio
CoStar Group has a trailing twelve months price to earnings ratio of 103.46. Meaning, the purchaser of the share is investing $103.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.27%.
Volatility
CoStar Group’s last week, last month’s, and last quarter’s current intraday variation average was 0.65%, 0.19%, and 1.24%.
CoStar Group’s highest amplitude of average volatility was 0.65% (last week), 1.37% (last month), and 1.24% (last quarter).
More news about CoStar Group.
Losers Today
1. Groupon (GRPN) – -30.71%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon sliding 30.71% to $12.59 on Friday while NASDAQ slid 0.96% to $15,973.17.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-4.5.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -567.07%.
Volume
Today’s last reported volume for Groupon is 9807910 which is 1081.53% above its average volume of 830100.
More news about Groupon.
2. TRACON Pharmaceuticals (TCON) – -30.65%
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors and lymphomas, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309; Case Western Reserve University for the development of TRC102; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.
NASDAQ ended the session with TRACON Pharmaceuticals falling 30.65% to $0.44 on Friday, following the last session’s downward trend. NASDAQ dropped 0.96% to $15,973.17, after two successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, TRACON Pharmaceuticals has a trailing twelve months EPS of $-0.11.
Volume
Today’s last reported volume for TRACON Pharmaceuticals is 20416400 which is 586.49% above its average volume of 2974010.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 83.3% and 75%, respectively.
Moving Average
TRACON Pharmaceuticals’s value is way above its 50-day moving average of $0.21 and way higher than its 200-day moving average of $0.25.
Earnings Before Interest, Taxes, Depreciation, and Amortization
TRACON Pharmaceuticals’s EBITDA is 0.96.
More news about TRACON Pharmaceuticals.
3. Adobe (ADBE) – -13.67%
Adobe Inc., together with its subsidiaries, operates as a diversified software company worldwide. It operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products, services, and solutions that enable individuals, teams, and enterprises to create, publish, and promote content; and Document Cloud, a unified cloud-based document services platform. Its flagship product is Creative Cloud, a subscription service that allows members to access its creative products. This segment serves content creators, students, workers, marketers, educators, enthusiasts, and communicators. The Digital Experience segment provides an integrated platform and set of applications and services that enable brands and businesses to create, manage, execute, measure, monetize, and optimize customer experiences from analytics to commerce. This segment serves marketers, advertisers, agencies, publishers, merchandisers, merchants, web analysts, data scientists, developers, and executives across the C-suite. The Publishing and Advertising segment offers products and services, such as e-learning solutions, technical document publishing, web conferencing, document and forms platform, web application development, and high-end printing, as well as Advertising Cloud offerings. It also provides consulting, technical support, and learning services. The company offers its products and services directly to enterprise customers through its sales force and local field offices, as well as to end users through app stores and through its website at adobe.com. It also distributes products and services through distributors, value-added resellers, systems integrators, software vendors and developers, retailers, and original equipment manufacturers. The company was formerly known as Adobe Systems Incorporated and changed its name to Adobe Inc. in October 2018. Adobe Inc. was founded in 1982 and is headquartered in San Jose, California.
NASDAQ ended the session with Adobe falling 13.67% to $492.46 on Friday, after two sequential sessions in a row of losses. NASDAQ dropped 0.96% to $15,973.17, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Adobe has a trailing twelve months EPS of $11.83.
PE Ratio
Adobe has a trailing twelve months price to earnings ratio of 41.63. Meaning, the purchaser of the share is investing $41.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.51%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Adobe’s EBITDA is 133.51.
Previous days news about Adobe
- Adobe systems (adbe) tops Q1 earnings and revenue estimates. According to Zacks on Thursday, 14 March, "While Adobe has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
More news about Adobe.
4. Zillow Group (Z) – -13.49%
Zillow Group, Inc. operates real estate brands in mobile applications and Websites in the United States. The company offers premier agent and rentals marketplaces, new construction marketplaces, advertising, display advertising, and business technology solutions, as well as dotloop and floor plans. It also provides mortgage originations and the sale of mortgages, and advertising to mortgage lenders and other mortgage professionals; and title and escrow services. In addition, the company's brand portfolio includes Zillow Premier Agent, Zillow Home Loans, Zillow Rentals, Trulia, StreetEasy, HotPads, and Out East; and a suite of marketing software and technology solutions for the real estate industry, including ShowingTime+, Spruce, and Follow Up Boss. Zillow Group, Inc. was incorporated in 2004 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Zillow Group dropping 13.49% to $47.71 on Friday while NASDAQ fell 0.96% to $15,973.17.
Earnings Per Share
As for profitability, Zillow Group has a trailing twelve months EPS of $-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.51%.
Moving Average
Zillow Group’s value is way below its 50-day moving average of $55.62 and under its 200-day moving average of $49.47.
Sales Growth
Zillow Group’s sales growth is 19.5% for the ongoing quarter and 18.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 5.7% and positive 10.3% for the next.
More news about Zillow Group.
5. Zillow Group (ZG) – -13.02%
Zillow Group, Inc. operates real estate brands in mobile applications and Websites in the United States. The company offers premier agent and rentals marketplaces, new construction marketplaces, advertising, display advertising, and business technology solutions, as well as dotloop and floor plans. It also provides mortgage originations and the sale of mortgages, and advertising to mortgage lenders and other mortgage professionals; and title and escrow services. In addition, the company's brand portfolio includes Zillow Premier Agent, Zillow Home Loans, Zillow Rentals, Trulia, StreetEasy, HotPads, and Out East; and a suite of marketing software and technology solutions for the real estate industry, including ShowingTime+, Spruce, and Follow Up Boss. Zillow Group, Inc. was incorporated in 2004 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Zillow Group falling 13.02% to $46.22 on Friday, after four sequential sessions in a row of losses. NASDAQ dropped 0.96% to $15,973.17, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Zillow Group has a trailing twelve months EPS of $-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.51%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Zillow Group’s EBITDA is 6.39.
Volume
Today’s last reported volume for Zillow Group is 2964600 which is 359.31% above its average volume of 645445.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Zillow Group’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
Zillow Group’s stock is valued at $46.22 at 17:32 EST, way under its 52-week high of $59.23 and way above its 52-week low of $33.23.
More news about Zillow Group.
6. Sutro Biopharma (STRO) – -12.06%
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
NASDAQ ended the session with Sutro Biopharma falling 12.06% to $4.01 on Friday, following the last session’s downward trend. NASDAQ slid 0.96% to $15,973.17, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Sutro Biopharma has a trailing twelve months EPS of $-2.91.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -100.83%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 32.7%, now sitting on 48.64M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sutro Biopharma’s EBITDA is 3.75.
Yearly Top and Bottom Value
Sutro Biopharma’s stock is valued at $4.01 at 17:32 EST, way below its 52-week high of $6.11 and way higher than its 52-week low of $2.01.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 20.6% and a negative 1.2%, respectively.
More news about Sutro Biopharma.
7. Scholar Rock Holding Corporation (SRRK) – -9.77%
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Scholar Rock Holding Corporation dropping 9.77% to $14.78 on Friday, after two sequential sessions in a row of losses. NASDAQ dropped 0.96% to $15,973.17, after two successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Scholar Rock Holding Corporation has a trailing twelve months EPS of $-1.95.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -68.96%.
Moving Average
Scholar Rock Holding Corporation’s value is under its 50-day moving average of $15.71 and way higher than its 200-day moving average of $10.91.
Volume
Today’s last reported volume for Scholar Rock Holding Corporation is 859134 which is 15.7% above its average volume of 742551.
Yearly Top and Bottom Value
Scholar Rock Holding Corporation’s stock is valued at $14.78 at 17:32 EST, way below its 52-week high of $21.17 and way higher than its 52-week low of $5.56.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 6.5% and positive 2% for the next.
More news about Scholar Rock Holding Corporation.
8. ToughBuilt Industries (TBLT) – -9.22%
ToughBuilt Industries, Inc. designs, develops, manufactures, and distributes home improvement and construction products for the building industry in the United States and internationally. It offers tool pouches, tool rigs, tool belts and accessories, tools bags, totes, various storage solutions, and office organizers/bags for laptop/tablet/cellphones, etc.; and kneepads. The company also provides sawhorses, miter saws, table saws, roller stands, and workbenches; sawhorse/jobsite tables; and digital measure and levels. It offers its products under the TOUGHBUILT brand through various home improvement big box stores, professional outlets, and direct marketing to construction companies and trade/wholesale outlets. The company was formerly known as Phalanx, Inc. and changed its name to ToughBuilt Industries, Inc. in December 2015. ToughBuilt Industries, Inc. was incorporated in 2012 and is based in Lake Forest, California.
NASDAQ ended the session with ToughBuilt Industries dropping 9.22% to $3.25 on Friday, after five successive sessions in a row of losses. NASDAQ slid 0.96% to $15,973.17, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, ToughBuilt Industries has a trailing twelve months EPS of $-197.6.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -176.68%.
Volume
Today’s last reported volume for ToughBuilt Industries is 66228 which is 5.99% below its average volume of 70448.
More news about ToughBuilt Industries.
9. DouYu (DOYU) – -8.94%
DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors professional players and teams, and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.
NASDAQ ended the session with DouYu falling 8.94% to $0.68 on Friday while NASDAQ dropped 0.96% to $15,973.17.
Earnings Per Share
As for profitability, DouYu has a trailing twelve months EPS of $0.06.
PE Ratio
DouYu has a trailing twelve months price to earnings ratio of 11.33. Meaning, the purchaser of the share is investing $11.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.08%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
DouYu’s EBITDA is 64.57.
Volatility
DouYu’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.33%, a negative 0.05%, and a positive 3.05%.
DouYu’s highest amplitude of average volatility was 4.14% (last week), 2.09% (last month), and 3.05% (last quarter).
Sales Growth
DouYu’s sales growth is negative 28.4% for the present quarter and negative 11.3% for the next.
More news about DouYu.
10. China SXT Pharmaceuticals (SXTC) – -8.33%
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of July 31, 2021, its end-customer base includes 70 pharmaceutical companies, 12 chain pharmacies, and 59 hospitals in 10 provinces and municipalities in China, including Jiangsu, Hubei, Shandong, Guangdong, Liaoning, Anhui, Henan, Jiangxi, Heilongjiang, and Hainan. The company was founded in 2005 and is based in Taizhou, China.
NASDAQ ended the session with China SXT Pharmaceuticals dropping 8.33% to $1.76 on Friday while NASDAQ slid 0.96% to $15,973.17.
Earnings Per Share
As for profitability, China SXT Pharmaceuticals has a trailing twelve months EPS of $-22.22.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.15%.
Moving Average
China SXT Pharmaceuticals’s worth is way under its 50-day moving average of $1.99 and way below its 200-day moving average of $3.18.
Revenue Growth
Year-on-year quarterly revenue growth declined by 51.5%, now sitting on 1.97M for the twelve trailing months.
Yearly Top and Bottom Value
China SXT Pharmaceuticals’s stock is valued at $1.76 at 17:32 EST, way below its 52-week high of $9.38 and way above its 52-week low of $1.56.
Volume
Today’s last reported volume for China SXT Pharmaceuticals is 96564 which is 91.22% below its average volume of 1100460.
More news about China SXT Pharmaceuticals.
Stay up to date with our winners and losers daily report